Skip to main content
. 2017 Sep 8;8(54):92079–92089. doi: 10.18632/oncotarget.20759

Figure 5. MicroRNA-92b-3p (miR-92b-3p) suppresses the hypertrophic phenotype of NMVCs in vitro.

Figure 5

(A) Morphologies of Ang-II-treated NMVCs as revealed by FITC-phalloidin staining. The scale bar is 50 μm. (B) ANP, ACTA1, β-MHC and MEF2D protein expression in NMVCs was detected by Western blot assay. Data are shown as mean ± sem, *p<0.05, **p<0.01. N=3.